| In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma E Lilienberg, IR Dubbelboer, A Karalli, R Axelsson, TB Brismar, ... Molecular pharmaceutics 14 (2), 448-458, 2017 | 38 | 2017 |
| Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting A Karalli, J Teiler, M Haji, E Seth, TB Brismar, S Wahlin, R Axelsson, ... Scandinavian Journal of Gastroenterology 54 (7), 905-912, 2019 | 22 | 2019 |
| Transarterial chemoembolization of renal cell carcinoma: a prospective controlled trial A Karalli, R Ghaffarpour, R Axelsson, L Lundell, B Bozoki, T Brismar, ... Journal of vascular and interventional radiology 28 (12), 1664-1672, 2017 | 22 | 2017 |
| Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma HP Marquez, A Karalli, H Haubenreisser, RP Mathew, H Alkadhi, ... European journal of radiology 91, 160-167, 2017 | 12 | 2017 |
| Reply to" Comment on'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'" IR Dubbelboer, E Lilienberg, A Karalli, R Axelsson, TB Brismar, ... Molecular pharmaceutics 15 (1), 336-340, 2018 | 1 | 2018 |
| Transarterial chemoembolization in primary liver and kidney malignancies A Karalli PQDT-Global, 2019 | | 2019 |
| Comparison of drug release, pharmacokinetics and pharmacodynamics after lipiodol-based emulsion or drug-eluting bead delivery to patients with hepatocellular carcinoma E Lilienberg, IR Dubbelboer, A Karalli, R Axelsson, TB Brismar, ... | | 2015 |
| Drug Eluting Beads vs. Lipiodol-based Emulsion regarding Local Drug Release and Effect in Patients with Hepatocellular Carcinoma–Interim Analysis of a Clinical Trial– E Lilienberg, IR Dubbelboer, A Karalli, P Stål, CE Barbier, A Norén, ... | | |
